Mahesh Vijaykant Nabar
Financieel Directeur/CFO bij Unidrug Innovative Pharma Technologies Ltd.
Profiel
Mahesh Vijaykant Nabar is currently the Chief Financial Officer at Unidrug Innovative Pharma Technologies Ltd.
He completed his undergraduate degree from the University of Rajasthan and his graduate degree from Devi Ahilya University.
Actieve functies van Mahesh Vijaykant Nabar
| Bedrijven | Functie | Begin |
|---|---|---|
Unidrug Innovative Pharma Technologies Ltd.
 Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Financieel Directeur/CFO | 01-08-2018 |
Opleiding van Mahesh Vijaykant Nabar
| University of Rajasthan | Undergraduate Degree |
| Devi Ahilya University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Unidrug Innovative Pharma Technologies Ltd.
Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Health Technology |
